PreprintResearch SquarePublished
A Novel ACLY Inhibitor Induces Transcriptional and Metabolic Reprogramming to Overcome Tyrosine kinase inhibitor Resistance in Lymphoma
Regional connection
Verified Author affiliations on the publisher record name Fox Chase Cancer Center, University of Pennsylvania, The Wistar Institute, with Temple Health linked by the institution reference. Affiliation source
Publication record
- Type
- Preprint
- Venue
- Research Square
- Published
- Topic
- Disease research
- PubMed ID
- 42996136
- PubMed Central ID
- PMC13738933
- Open access
- Yes, open
- Added to directory
- Source checked